Uniform dose formulation is key to meeting safety study requirements. Homogeneity or uniformity of a dose formulation is a requirement for ensuring integrity of regulated preclinical safety studies.
Additionally, Content Uniformity (CU), which relies heavily on the proper blend uniformity of the final pharmaceutical product, must be verified for product release. During the development process, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results